IQVIA Holdings EBITDA 2011-2024 | IQV

IQVIA Holdings annual and quarterly EBITDA history from 2011 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • IQVIA Holdings EBITDA for the quarter ending September 30, 2024 was $0.833B, a 6.39% increase year-over-year.
  • IQVIA Holdings EBITDA for the twelve months ending September 30, 2024 was $3.225B, a 6.16% increase year-over-year.
  • IQVIA Holdings 2023 annual EBITDA was $3.12B, a 5.98% increase from 2022.
  • IQVIA Holdings 2022 annual EBITDA was $2.944B, a 10.1% increase from 2021.
  • IQVIA Holdings 2021 annual EBITDA was $2.674B, a 31.34% increase from 2020.
IQVIA Holdings Annual EBITDA
(Millions of US $)
2023 $3,120
2022 $2,944
2021 $2,674
2020 $2,036
2019 $1,992
2018 $1,893
2017 $1,728
2016 $926
2015 $793
2014 $718
2013 $592
2012 $504
2011 $467
2010 $498
IQVIA Holdings Quarterly EBITDA
(Millions of US $)
2024-09-30 $833
2024-06-30 $795
2024-03-31 $775
2023-12-31 $822
2023-09-30 $783
2023-06-30 $787
2023-03-31 $728
2022-12-31 $740
2022-09-30 $724
2022-06-30 $726
2022-03-31 $754
2021-12-31 $728
2021-09-30 $642
2021-06-30 $634
2021-03-31 $670
2020-12-31 $638
2020-09-30 $511
2020-06-30 $375
2020-03-31 $512
2019-12-31 $483
2019-09-30 $507
2019-06-30 $494
2019-03-31 $508
2018-12-31 $504
2018-09-30 $467
2018-06-30 $454
2018-03-31 $468
2017-12-31 $423
2017-09-30 $453
2017-06-30 $413
2017-03-31 $439
2016-12-31 $295
2016-09-30 $232
2016-06-30 $183
2016-03-31 $216
2015-12-31 $219
2015-09-30 $205
2015-06-30 $194
2015-03-31 $175
2014-12-31 $193
2014-09-30 $181
2014-06-30 $172
2014-03-31 $172
2013-12-31 $162
2013-09-30 $154
2013-06-30 $132
2013-03-31 $143
2012-12-31 $124
2012-09-30 $137
2012-06-30 $127
2012-03-31 $117
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.284B $14.984B
IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.781B 26.81
Intuitive Surgical (ISRG) United States $217.430B 113.68
Alcon (ALC) Switzerland $43.790B 29.30
Edwards Lifesciences (EW) United States $40.720B 25.86
IDEXX Laboratories (IDXX) United States $35.259B 41.52
DexCom (DXCM) United States $34.017B 51.23
Waters (WAT) United States $24.246B 35.85
STERIS (STE) Ireland $21.575B 24.84
SONOVA HOLDING (SONVY) Switzerland $20.893B 0.00
Hologic (HOLX) United States $16.069B 17.45
Fresenius Medical Care AG KGaA (FMS) Germany $13.597B 13.96
Globus Medical (GMED) United States $12.707B 32.18
Sysmex ADR (SSMXY) Japan $11.852B 37.16
Penumbra (PEN) United States $10.587B 103.70
Masimo (MASI) United States $9.271B 44.86
Glaukos (GKOS) United States $8.829B 0.00
Teleflex (TFX) United States $8.395B 13.39
Integer Holdings (ITGR) United States $4.744B 26.89
Inari Medical (NARI) United States $4.650B 0.00
PROCEPT BioRobotics (PRCT) United States $3.570B 0.00
Veracyte (VCYT) United States $3.336B 100.12
LivaNova (LIVN) United Kingdom $2.642B 15.25
Nihon Kohden (NHNKY) Japan $2.325B 17.66
Tandem Diabetes Care (TNDM) United States $2.299B 0.00
Elekta AB (EKTAY) Sweden $2.235B 20.10
TransMedics (TMDX) United States $2.080B 65.93
Integra LifeSciences Holdings (IART) United States $1.918B 10.02
Alphatec Holdings (ATEC) United States $1.614B 0.00
Artivion (AORT) United States $1.290B 85.50
RxSight (RXST) United States $1.286B 0.00
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.979B 0.00
AxoGen (AXGN) United States $0.831B 0.00
Mesa Laboratories (MLAB) United States $0.787B 18.55
IRadimed (IRMD) United States $0.752B 40.63
AVANOS MEDICAL, INC (AVNS) United States $0.729B 12.39
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
SiBone (SIBN) United States $0.698B 0.00
OrthoPediatrics (KIDS) United States $0.657B 0.00
Treace Medical Concepts (TMCI) United States $0.587B 0.00
Semler Scientific (SMLR) United States $0.576B 30.30
Pacific Biosciences Of California (PACB) United States $0.496B 0.00
ClearPoint Neuro (CLPT) United States $0.494B 0.00
AngioDynamics (ANGO) United States $0.488B 0.00
Delcath Systems (DCTH) United States $0.486B 0.00
NeuroPace (NPCE) United States $0.419B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.417B 22.57
Alpha Tau Medical (DRTS) Israel $0.279B 0.00
Inogen (INGN) United States $0.258B 0.00
Accuray (ARAY) United States $0.229B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.115B 12.26
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
908 Devices (MASS) United States $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.076B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Neuronetics (STIM) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Rapid Micro Biosystems (RPID) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
Lucid Diagnostics (LUCD) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00